CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

Figure 3

Expression of CD24 protein in glioma and nonneoplastic brain tissues by Western blot analysis. (a) CD24 expression levels in glioma and nonneoplastic brain tissues. (b) CD24 expression levels in glioma with different WHO grades. (c) CD24 expression levels in nonneoplastic brain tissues and glioma with different WHO grades. “N” refers to nonneoplastic brain tissues; “Ca” refers to glioma tissues; “Ca_ I” ~ “Ca_ IV” refer to glioma tissues with WHO grade I~IV. β-actin was used as a control for equal protein loading. Values are means ± SD. “*”, 𝑃<0.05, comparison with nonneoplastic brain tissues; “**”, 𝑃<0.01, comparison with nonneoplastic brain tissues.

(a)

(b)

(c)